Related references
Note: Only part of the references are listed.Differential effects of bexarotene on intrinsic and extrinsic pathways in TRAIL-induced apoptosis in two myeloid leukemia cell lines
Shao Xu Ying et al.
LEUKEMIA & LYMPHOMA (2007)
Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32)
P. Conti et al.
AUTOIMMUNITY REVIEWS (2007)
IL-32, a novel cytokine with a possible role in disease
C. A. Dinarello et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor
Jonathan C. Trent et al.
CANCER (2006)
Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members
Michael Certo et al.
CANCER CELL (2006)
Serum circulating human mRNA profiling and its utility for oral cancer detection
Y Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays
YL Wang et al.
BMC GENOMICS (2006)
Microenvironmental niches in the bone marrow required for B-cell development
T Nagasawa
NATURE REVIEWS IMMUNOLOGY (2006)
Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases
Hirofumi Shoda et al.
ARTHRITIS RESEARCH & THERAPY (2006)
NF-κB and FLEP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs)
DMB Kerbauy et al.
BLOOD (2005)
Natural-killer cells and dendritic cells: l' union fait la force
T Walzer et al.
BLOOD (2005)
Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis
HD Yuan et al.
ONCOGENE (2005)
Identification and hematopoietic potential of CD45- clonal cells with very immature phenotype (CD45-CD34-CD38-Lin-) in patients with myelodysplastic syndromes
K Ogata et al.
STEM CELLS (2005)
Mesenchymal stem cells in myelodysplastic syndromes:: phenotypic and cytogenetic characterization
E Flores-Figueroa et al.
LEUKEMIA RESEARCH (2005)
Targeting NF-κB activation via pharmacologic inhibition of IKK2-induced apoptosis of human acute myeloid leukemia cells
C Frelin et al.
BLOOD (2005)
Targeted therapies in myelodysplastic syndromes: ASH 2003 review
A Candoni et al.
SEMINARS IN HEMATOLOGY (2004)
Single-stranded linear amplification protocol results in reproducible and reliable microarray data from nanogram amounts of starting RNA
DL Stirewalt et al.
GENOMICS (2004)
To the editor:: Engraftment of distinct clonal MDS-derived hematopoietic precursors in NOD/SCID-β2-microglobulin-deficient mice after intramedullary transplantation of hematopoietic and stromal cells
DMB Kerbauy et al.
BLOOD (2004)
Simultaneous demonstration of clonal chromosome abnormalities and apoptosis in individual marrow cells in myelodysplastic syndrome
X Li et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2004)
Expression and function of IL-7 receptors in marrow stromal cells
M Pillai et al.
LEUKEMIA & LYMPHOMA (2004)
Remicade as TNF suppressor in patients with myelodysplastic syndromes
A Raza et al.
LEUKEMIA & LYMPHOMA (2004)
Chelerythrin activates caspase-8, downregulates FLIP long and short, and overcomes resistance to tumour necrosis factor-related apoptosis-inducing ligand in KG1a cells
U Platzbecker et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
NOD/SCID mice transplanted with marrow from patients with myelodysplastic syndrome (MDS) show long-term propagation of normal but not clonal human precursors
AI Benito et al.
LEUKEMIA RESEARCH (2003)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias
BM Bolstad et al.
BIOINFORMATICS (2003)
A regression-based method to identify differentially expressed genes in microarray time course studies and its application in an inducible Huntington's disease transgenic model
XL Xu et al.
HUMAN MOLECULAR GENETICS (2002)
Gene expression profiling of the functionally distinct human bone marrow stromal cell lines HS-5 and HS-27a
L Graf et al.
BLOOD (2002)
In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome
E Flores-Figueroa et al.
LEUKEMIA RESEARCH (2002)
A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)-Fc fusion protein in patients with myelodysplastic syndrome
JP Maciejewski et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Soluble TNF receptor fusion protein (etanercept) for the treatment of myelodysplastic syndrome: A pilot study
HJ Deeg et al.
LEUKEMIA (2002)
Role of protein kinase C ζ isoform in Fas resistance of immature myeloid KG1a leukemic cells
A de Thonel et al.
BLOOD (2001)
Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis
DY Zang et al.
BLOOD (2001)
Prognostic evaluation of the microvascular network in myelodysplastic syndromes
P Korkolopoulou et al.
LEUKEMIA (2001)
Significance of angiogenin plasma concentrations in patients with acute myeloid leukaemia and advanced myelodysplastic syndrome
S Verstovsek et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Statistical modeling of large microarray data sets to identify stimulus-response profiles
LP Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes
WT Bellamy et al.
BLOOD (2001)
Abnormalities of adherent layers grown from bone marrow of patients with myelodysplasia
GB Tennant et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Share Paper
